Opinion: BRIC by BRIC – a geopolitical analysis of Brazil’s “Covaxin” cause célèbre

Bharat Biotech is an Indian manufacturer whose homegrown Covaxin brand was seeking international recognition. Brazil agreed to purchase 20 million doses. India’s government, anxious to promote an eponymous vaccine – “Bharat” is the country’s name in Hindi - readily agreed to the purchase.

RIO DE JANEIRO, BRAZIL – (Opinion) All but one of the so-called BRICS countries – Brazil, Russia, India, China, but not South Africa – are today engaged in a “soft power” exercise that is called “vaccine diplomacy”: sometimes their interests are mutual, sometimes at cross purposes.

China, where the coronavirus causing Covid-19 first arose, has been trying to apologize by becoming the leader in promoting vaccines to prevent the disease. Chinese pharmaceutical giants Sinopharm and Sinovac have rolled out billions of doses of the finished product and of the active pharmaceutical ingredient (API) needed for their manufacture.

Detail: Coronavac, the vaccine . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?